
CAS 1131640-69-1
:Formula:C23H23ClFNO5
InChI:InChI=1S/C23H23ClFNO5/c1-12(2)19(11-27)26-10-16(23(29)30)22(28)15-8-14(20(31-3)9-18(15)26)7-13-5-4-6-17(24)21(13)25/h4-6,8-10,12,19,27H,7,11H2,1-3H3,(H,29,30)/t19-/m1/s1/i3D3,7D2
InChI key:JUZYLCPPVHEVSV-BRJATZNPSA-N
SMILES:[2H]C([2H])([2H])OC1=CC2=C(C=C1C([2H])([2H])C3=C(C(=CC=C3)Cl)F)C(=O)C(=CN2[C@H](CO)C(C)C)C(=O)O
Filter by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 2 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
Elvitegravir-d5
CAS:Elvitegravir-d5 (GS-9137-d5; JTK-303-d5; D06677-d5) is the deuterium-labeled form of Elvitegravir. Elvitegravir (GS-9137; JTK-303; D06677) is an HIV integrase inhibitor, targeting HIV-1IIIB, HIV-2EHO, and HIV-2ROD with IC50 values of 0.7 nM, 2.8 nM, and 1.4 nM, respectively.Formula:C23H23ClFNO5Molecular weight:452.92Elvitegravir-d6 (Major)
CAS:Controlled ProductApplications A novel labelled inhibitor of human immunodeficiency virus type 1 integrase.
References Chou, T., et al.: Eur. J. Biochem., 115, 207 (1981), Baba, M., et al.: Antimicrob. Agents Chemother., 31, 1613 (1987), Craigie, R., et al.: J. Biol. Chem., 276, 23213 (2001), Chen, X., et al.: J. Mol. Biol., 380, 504 (2008),Formula:C23H17D6ClFNO5Color and Shape:NeatMolecular weight:453.91


